de Boer, Stephanie M
Powell, Melanie E
Mileshkin, Linda
Katsaros, Dionyssios
Bessette, Paul
Haie-Meder, Christine
Ottevanger, Petronella B
Ledermann, Jonathan A
Khaw, Pearly
Colombo, Alessandro
Fyles, Anthony
Baron, Marie-Helene
Jürgenliemk-Schulz, Ina M
Kitchener, Henry C
Nijman, Hans W
Wilson, Godfrey
Brooks, Susan
Carinelli, Silvestro
Provencher, Diane
Hanzen, Chantal
Lutgens, Ludy C H W
Smit, Vincent T H B M
Singh, Naveena
Do, Viet
D'Amico, Romerai
Nout, Remi A
Feeney, Amanda
Verhoeven-Adema, Karen W
Putter, Hein
Creutzberg, Carien L
McCormack, Mary
Whitmarsh, Karen
Allerton, Rozenn
Gregory, Deborah
Symonds, Paul
Hoskin, Peter J.
Adusumalli, Madhavi
Anand, Anjana
Wade, Robert
Stewart, Alexandra
Taylor, Wendy
Kruitwagen, Roy F.P.M.
Hollema, Harry
Pras, Elizabeth
Snyers, An
Stalpers, Lukas
Jobsen, Jan J.
Slot, Annerie
Mens, Jan-Willem M.
Stam, Tanja C.
Van Triest, Baukelien
Van der Steen - Banasik, Elzbieta M.
De Winter, Karin A.J.
Quinn, Michael A.
Kolodziej, Ilka
Pyman, Jan
Johnson, Carol
Capp, Anne
Fossati, Roldano
Gribaudo, Sergio
Lissoni, Andrea A.
Ferrero, Annamaria
Artioli, Grazia
Davidson, Cathy
McLachlin, C. Meg
Ghatage, Prafull
Rittenberg, Paula V.C.
Souhami, Luis
Thomas, Gillian
Duvillard, Pierre
Berton-Rigaud, Dominique
Tubiana-Mathieu, Nicole
This article is maintained by: Elsevier
Article Title: Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
Journal Title: The Lancet Oncology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S1470-2045(18)30079-2
CrossRef DOI link to the associated document: https://doi.org/10.1016/S1470-2045(18)30091-3
Content Type: article
Copyright: © 2018 The Authors. Published by Elsevier Ltd.